Caminiti Fabrizia, De Salvo Simona, De Cola Maria Cristina, Russo Margherita, Bramanti Placido, Marino Silvia, Ciurleo Rosella
IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy.
IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy; Department of Biomedical Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy.
PLoS One. 2014 Jul 21;9(7):e103151. doi: 10.1371/journal.pone.0103151. eCollection 2014.
Several studies reported olfactory dysfunction in patients with multiple sclerosis. The estimate of the incidence of olfactory deficits in multiple sclerosis is uncertain; this may arise from different testing methods that may be influenced by patients' response bias and clinical, demographic and cognitive features.
To evaluate objectively the olfactory function using Olfactory Event Related Potentials.
We tested the olfactory function of 30 patients with relapsing remitting multiple sclerosis (mean age of 36.03±6.96 years) and of 30 age, sex and smoking-habit matched healthy controls by using olfactory potentials. A selective and controlled stimulation of the olfactory system to elicit the olfactory event related potentials was achieved by a computer-controlled olfactometer linked directly with electroencephalograph. Relationships between olfactory potential results and patients' clinical characteristics, such as gender, disability status score, disease-modifying therapy, and disease duration, were evaluated.
Seven of 30 patients did not show olfactory event related potentials. Sixteen of remaining 23 patients had a mean value of amplitude significantly lower than control group (p<0.01). The presence/absence of olfactory event related potentials was associated with dichotomous expanded disability status scale (p = 0.0433), as well as inversely correlated with the disease duration (r = -0.3641, p = 0.0479).
Unbiased olfactory dysfunction of different severity found in multiple sclerosis patients suggests an organic impairment which could be related to neuroinflammatory and/or neurodegenerative processes of olfactory networks, supporting the recent findings on neurophysiopathology of disease.
多项研究报告了多发性硬化症患者存在嗅觉功能障碍。多发性硬化症嗅觉缺陷的发病率估计尚不确定;这可能源于不同的测试方法,这些方法可能受到患者反应偏差以及临床、人口统计学和认知特征的影响。
使用嗅觉事件相关电位客观评估嗅觉功能。
我们通过嗅觉电位测试了30例复发缓解型多发性硬化症患者(平均年龄36.03±6.96岁)以及30名年龄、性别和吸烟习惯相匹配的健康对照者的嗅觉功能。通过直接与脑电图仪相连的计算机控制嗅觉计,对嗅觉系统进行选择性和控制性刺激,以诱发嗅觉事件相关电位。评估了嗅觉电位结果与患者临床特征(如性别、残疾状态评分、疾病修饰治疗和病程)之间的关系。
30例患者中有7例未显示嗅觉事件相关电位。其余23例患者中有16例的平均波幅显著低于对照组(p<0.01)。嗅觉事件相关电位的有无与二分法扩展残疾状态量表相关(p = 0.0433),并且与病程呈负相关(r = -0.3641,p = 0.0479)。
在多发性硬化症患者中发现的不同严重程度的无偏差嗅觉功能障碍提示存在器质性损害,这可能与嗅觉网络的神经炎症和/或神经退行性过程有关,支持了该疾病神经生理病理学的最新研究结果。